0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Local Anesthesia Drugs Market Size, Share & Trends Analysis Report by Drug (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), Application (Injectable, Surface Anesthetic), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5998671
The Local Anesthesia Drugs Market was valued at USD 4.14 billion in 2024, and is projected to reach USD 5.13 billion by 2030, rising at a CAGR of 3.70%. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

Local Anesthesia Drugs Market Report Highlights

  • By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period.
  • North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region.
  • Asia-Pacific local anesthesia drugs industry is anticipated to witness the fastest CAGR over the forecast period due to rapid urbanization and improvements in healthcare infrastructure.
  • By Drug segment, Lidocaine dominated the market with a 28.88% share in 2024, driven by its extensive use in injectable and topical anesthetic formulations.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug
1.2.2. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Local Anesthesia Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.3.1. Phase 1
3.3.3.2. Phase 2
3.3.3.3. Phase 3
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Local Anesthesia Drugs Market: Drug Business Analysis
4.1. Drug Market Share, 2024 & 2030
4.2. Drug Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
4.4. Bupivacaine
4.4.1. Bupivacaine Market, 2018-2030 (USD Million)
4.5. Ropivacaine
4.5.1. Ropivacaine Market, 2018-2030 (USD Million)
4.6. Lidocaine
4.6.1. Lidocaine Market, 2018-2030 (USD Million)
4.7. Chloroprocaine
4.7.1. Chloroprocaine Market, 2018-2030 (USD Million)
4.8. Prilocaine
4.8.1. Prilocaine Market, 2018-2030 (USD Million)
4.9. Benzocaine
4.9.1. Benzocaine Market, 2018-2030 (USD Million)
4.10. Others
4.10.1. Others Market, 2018-2030 (USD Million)
Chapter 5. Local Anesthesia Drugs Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Injectable
5.4.1. Injectable Market, 2018-2030 (USD Million)
5.5. Surface Anesthetic
5.5.1. Surface Anesthetic Market, 2018-2030 (USD Million)
Chapter 6. Local Anesthesia Drugs Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.4. North America
6.4.1. North America Local Anesthesia Drugs Market Estimates and Forecasts, By Country, 2018-2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Europe
6.5.1. Europe Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Local Anesthesia Drugs Market Estimates and Forecasts, 2017-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Local Anesthesia Drugs Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Johnson & Johnson Services, Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Pfizer Inc
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. AstraZeneca
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Novartis AG
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Teva Pharmaceutical Industries Ltd.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. GSK plc
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Sanofi
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Merck & Co., Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Aspen Holdings
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Viatris Inc.
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global local anesthesia drugs market, by region, 2018-2030 (USD Million)
Table 4 Global local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 5 Global local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 6 North America local anesthesia drugs market, by country, 2018-2030 (USD Million)
Table 7 North America local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 8 North America local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 9 U.S. local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 10 U.S. local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 11 Canada local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 12 Canada local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 13 Mexico local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 14 Mexico local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 15 Europe local anesthesia drugs market, by country, 2018-2030 (USD Million)
Table 16 Europe local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 17 Europe local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 18 UK local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 19 UK local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 20 Germany local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 21 Germany local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 22 France local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 23 France local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 24 Italy local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 25 Italy local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 26 Spain local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 27 Spain local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 28 Norway local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 29 Norway local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 30 Denmark local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 31 Denmark local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 32 Sweden local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 33 Sweden local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 34 Asia Pacific local anesthesia drugs market, by country, 2018-2030 (USD Million)
Table 35 Asia Pacific local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 36 Asia Pacific local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 37 Japan local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 38 Japan local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 39 China local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 40 China local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 41 India local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 42 India local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 43 Australia local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 44 Australia local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 45 South Korea local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 46 South Korea local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 47 Thailand local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 48 Thailand local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 49 Latin America local anesthesia drugs market, by country, 2018-2030 (USD Million)
Table 50 Latin America local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 51 Latin America local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 52 Brazil local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 53 Brazil local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 54 Argentina local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 55 Argentina local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 56 Middle East & Africa local anesthesia drugs market, by country, 2018-2030 (USD Million)
Table 57 Middle East & Africa local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 58 Middle East & Africa local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 59 South Africa local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 60 South Africa local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 61 Saudi Arabia local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 62 Saudi Arabia local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 63 UAE local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 64 UAE local anesthesia drugs market, by application, 2018-2030 (USD Million)
Table 65 Kuwait local anesthesia drugs market, by drug, 2018-2030 (USD Million)
Table 66 Kuwait local anesthesia drugs market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Local anesthesia drugs market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Segment snapshot
Figure 10 Competitive landscape
Figure 11 Local anesthesia drugs market dynamics
Figure 12 Local anesthesia drugs market: Porter’s five forces analysis
Figure 13 Local anesthesia drugs market: PESTLE analysis
Figure 14 Drug market, 2018-2030 (USD Million)
Figure 15 Bupivacaine market, 2018-2030 (USD Million)
Figure 16 Ropivacaine market, 2018-2030 (USD Million)
Figure 17 Lidocaine market, 2018-2030 (USD Million)
Figure 18 Chloroprocaine market, 2018-2030 (USD Million)
Figure 19 Prilocaine market, 2018-2030 (USD Million)
Figure 20 Benzocaine market, 2018-2030 (USD Million)
Figure 21 Others market, 2018-2030 (USD Million)
Figure 22 Application market, 2018-2030 (USD Million)
Figure 23 Injectable market, 2018-2030 (USD Million)
Figure 24 Surface Anesthetic market, 2018-2030 (USD Million)
Figure 25 Local anesthesia drugs market revenue, by region
Figure 26 Regional marketplace: Key takeaways
Figure 27 North America local anesthesia drugs market, 2018-2030 (USD Million)
Figure 28 U.S. country dynamics
Figure 29 U.S. local anesthesia drugs market, 2018-2030 (USD Million)
Figure 30 Canada country dynamics
Figure 31 Canada local anesthesia drugs market, 2018-2030 (USD Million)
Figure 32 Mexico country dynamics
Figure 33 Mexico local anesthesia drugs market, 2018-2030 (USD Million)
Figure 34 Europe local anesthesia drugs market, 2018-2030 (USD Million)
Figure 35 UK country dynamics
Figure 36 UK local anesthesia drugs market, 2018-2030 (USD Million)
Figure 37 Germany country dynamics
Figure 38 Germany local anesthesia drugs market, 2018-2030 (USD Million)
Figure 39 France country dynamics
Figure 40 France local anesthesia drugs market, 2018-2030 (USD Million)
Figure 41 Italy country dynamics
Figure 42 Italy local anesthesia drugs market, 2018-2030 (USD Million)
Figure 43 Spain country dynamics
Figure 44 Spain local anesthesia drugs market, 2018-2030 (USD Million)
Figure 45 Norway country dynamics
Figure 46 Norway local anesthesia drugs market, 2018-2030 (USD Million)
Figure 47 Sweden country dynamics
Figure 48 Sweden local anesthesia drugs market, 2018-2030 (USD Million)
Figure 49 Denmark country dynamics
Figure 50 Denmark local anesthesia drugs market, 2018-2030 (USD Million)
Figure 51 Asia Pacific local anesthesia drugs market, 2018-2030 (USD Million)
Figure 52 Japan country dynamics
Figure 53 Japan local anesthesia drugs market, 2018-2030 (USD Million)
Figure 54 China country dynamics
Figure 55 China local anesthesia drugs market, 2018-2030 (USD Million)
Figure 56 India country dynamics
Figure 57 India local anesthesia drugs market, 2018-2030 (USD Million)
Figure 58 Australia country dynamics
Figure 59 Australia local anesthesia drugs market, 2018-2030 (USD Million)
Figure 60 South Korea country dynamics
Figure 61 South Korea local anesthesia drugs market, 2018-2030 (USD Million)
Figure 62 Thailand country dynamics
Figure 63 Thailand local anesthesia drugs market, 2018-2030 (USD Million)
Figure 64 Latin America local anesthesia drugs market, 2018-2030 (USD Million)
Figure 65 Brazil country dynamics
Figure 66 Brazil local anesthesia drugs market, 2018-2030 (USD Million)
Figure 67 Argentina country dynamics
Figure 68 Argentina local anesthesia drugs market, 2018-2030 (USD Million)
Figure 69 MEA local anesthesia drugs market, 2018-2030 (USD Million)
Figure 70 South Africa country dynamics
Figure 71 South Africa local anesthesia drugs market, 2018-2030 (USD Million)
Figure 72 Saudi Arabia country dynamics
Figure 73 Saudi Arabia local anesthesia drugs market, 2018-2030 (USD Million)
Figure 74 UAE country dynamics
Figure 75 UAE local anesthesia drugs market, 2018-2030 (USD Million)
Figure 76 Kuwait country dynamics
Figure 77 Kuwait local anesthesia drugs market, 2018-2030 (USD Million)
Figure 78 Company categorization
Figure 79 Company market position analysis, 2024
Figure 80 Strategic framework

Companies Mentioned

The major companies featured in this Local Anesthesia Drugs market report include:
  • Johnson & Johnson Services, Inc
  • Pfizer Inc.
  • AstraZeneca plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • GSK plc
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Aspen Holdings
  • Viatris Inc.

Table Information